Cargando…

25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study

BACKGROUND: Low 25‐hydroxyvitamin D (25[OH]D) is associated with increased cardiovascular disease risk. Less known is whether 25(OH)D deficiency contributes to subclinical myocardial damage and wall stress (high‐sensitivity cardiac troponin T [hs‐cTnT] and N‐terminal pro–brain natriuretic peptide [N...

Descripción completa

Detalles Bibliográficos
Autores principales: Michos, Erin D., Selvin, Elizabeth, Misialek, Jeffrey R., McEvoy, John W., Ndumele, Chiadi E., Folsom, Aaron R., Ballantyne, Christie M., Lutsey, Pamela L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210331/
https://www.ncbi.nlm.nih.gov/pubmed/27821403
http://dx.doi.org/10.1161/JAHA.116.003575
_version_ 1782490863425814528
author Michos, Erin D.
Selvin, Elizabeth
Misialek, Jeffrey R.
McEvoy, John W.
Ndumele, Chiadi E.
Folsom, Aaron R.
Ballantyne, Christie M.
Lutsey, Pamela L.
author_facet Michos, Erin D.
Selvin, Elizabeth
Misialek, Jeffrey R.
McEvoy, John W.
Ndumele, Chiadi E.
Folsom, Aaron R.
Ballantyne, Christie M.
Lutsey, Pamela L.
author_sort Michos, Erin D.
collection PubMed
description BACKGROUND: Low 25‐hydroxyvitamin D (25[OH]D) is associated with increased cardiovascular disease risk. Less known is whether 25(OH)D deficiency contributes to subclinical myocardial damage and wall stress (high‐sensitivity cardiac troponin T [hs‐cTnT] and N‐terminal pro–brain natriuretic peptide [NT‐proBNP]) or whether associations vary among subgroups. METHODS AND RESULTS: Overall, 11 311 Atherosclerosis Risk in Communities participants without prevalent cardiovascular disease had 25(OH)D, hs‐cTnT, and NT‐proBNP measured at baseline (1990–1992), and 8990 had measurements of hs‐cTnT and NT‐proBNP repeated 6 years later. We examined associations of deficient 25(OH)D (<20 ng/mL) with prevalent elevated hs‐cTnT (≥14 ng/L) and NT‐proBNP (≥100 pg/mL), change in hs‐cTnT and NT‐proBNP, and incident elevated hs‐cTnT and NT‐proBNP. We tested for interactions by age (<56 and ≥56 years), sex, and race. In fully adjusted models, 25(OH)D was not associated with prevalent elevated hs‐cTnT and NT‐proBNP. Deficient 25(OH)D, however, was associated with increased 6‐year change in hs‐cTnT (β=0.54 ng/L [95% CI 0.08–1.01]) but not change in NT‐proBNP. Deficiency in 25(OH)D was not associated with incident elevated hs‐cTnT in the overall cohort but was associated with incident elevated hs‐cTnT in younger but not older adults (relative risk 2.18 [95% CI 1.21–3.94] versus 0.78 [95% CI 0.56–1.08], respectively; P=0.01 for interaction by age). Deficient 25(OH)D was also associated with incident elevated NT‐proBNP in men but not women (P=0.01 for interaction by sex). CONCLUSIONS: Vitamin D deficiency was associated with increased 6‐year change in hs‐cTnT levels. Hypothesis‐generating differences in associations by age and sex, but not race, were observed. If these associations are causal, further research is needed to understand mechanisms by which low 25(OH)D confers increased risk in these subgroups and whether treating deficient 25(OH)D can prevent myocardial damage and wall stress.
format Online
Article
Text
id pubmed-5210331
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52103312017-01-05 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study Michos, Erin D. Selvin, Elizabeth Misialek, Jeffrey R. McEvoy, John W. Ndumele, Chiadi E. Folsom, Aaron R. Ballantyne, Christie M. Lutsey, Pamela L. J Am Heart Assoc Original Research BACKGROUND: Low 25‐hydroxyvitamin D (25[OH]D) is associated with increased cardiovascular disease risk. Less known is whether 25(OH)D deficiency contributes to subclinical myocardial damage and wall stress (high‐sensitivity cardiac troponin T [hs‐cTnT] and N‐terminal pro–brain natriuretic peptide [NT‐proBNP]) or whether associations vary among subgroups. METHODS AND RESULTS: Overall, 11 311 Atherosclerosis Risk in Communities participants without prevalent cardiovascular disease had 25(OH)D, hs‐cTnT, and NT‐proBNP measured at baseline (1990–1992), and 8990 had measurements of hs‐cTnT and NT‐proBNP repeated 6 years later. We examined associations of deficient 25(OH)D (<20 ng/mL) with prevalent elevated hs‐cTnT (≥14 ng/L) and NT‐proBNP (≥100 pg/mL), change in hs‐cTnT and NT‐proBNP, and incident elevated hs‐cTnT and NT‐proBNP. We tested for interactions by age (<56 and ≥56 years), sex, and race. In fully adjusted models, 25(OH)D was not associated with prevalent elevated hs‐cTnT and NT‐proBNP. Deficient 25(OH)D, however, was associated with increased 6‐year change in hs‐cTnT (β=0.54 ng/L [95% CI 0.08–1.01]) but not change in NT‐proBNP. Deficiency in 25(OH)D was not associated with incident elevated hs‐cTnT in the overall cohort but was associated with incident elevated hs‐cTnT in younger but not older adults (relative risk 2.18 [95% CI 1.21–3.94] versus 0.78 [95% CI 0.56–1.08], respectively; P=0.01 for interaction by age). Deficient 25(OH)D was also associated with incident elevated NT‐proBNP in men but not women (P=0.01 for interaction by sex). CONCLUSIONS: Vitamin D deficiency was associated with increased 6‐year change in hs‐cTnT levels. Hypothesis‐generating differences in associations by age and sex, but not race, were observed. If these associations are causal, further research is needed to understand mechanisms by which low 25(OH)D confers increased risk in these subgroups and whether treating deficient 25(OH)D can prevent myocardial damage and wall stress. John Wiley and Sons Inc. 2016-11-07 /pmc/articles/PMC5210331/ /pubmed/27821403 http://dx.doi.org/10.1161/JAHA.116.003575 Text en © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Michos, Erin D.
Selvin, Elizabeth
Misialek, Jeffrey R.
McEvoy, John W.
Ndumele, Chiadi E.
Folsom, Aaron R.
Ballantyne, Christie M.
Lutsey, Pamela L.
25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
title 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
title_full 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
title_fullStr 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
title_full_unstemmed 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
title_short 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
title_sort 25‐hydroxyvitamin d levels and markers of subclinical myocardial damage and wall stress: the atherosclerosis risk in communities study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210331/
https://www.ncbi.nlm.nih.gov/pubmed/27821403
http://dx.doi.org/10.1161/JAHA.116.003575
work_keys_str_mv AT michoserind 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy
AT selvinelizabeth 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy
AT misialekjeffreyr 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy
AT mcevoyjohnw 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy
AT ndumelechiadie 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy
AT folsomaaronr 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy
AT ballantynechristiem 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy
AT lutseypamelal 25hydroxyvitamindlevelsandmarkersofsubclinicalmyocardialdamageandwallstresstheatherosclerosisriskincommunitiesstudy